Cognitive Dysfunction Is Sustained after Rescue Therapy in Experimental Cerebral Malaria, and Is Reduced by Additive Antioxidant Therapy
Patrícia A. Reis(Fundação Oswaldo Cruz), Hugo C. Castro‐Faria‐Neto(Fundação Oswaldo Cruz), Flávia Carvalho Alcântara Gomes(Universidade Federal do Rio de Janeiro), Válber S. Frutuoso(Fundação Oswaldo Cruz), Ive M. Sab(Fundação Oswaldo Cruz), Fernanda V. Hermani(Universidade do Extremo Sul Catarinense), Patrı́cia T. Bozza(Fundação Oswaldo Cruz), Guy A. Zimmerman(University of Utah), Marcus F. Oliveira(Universidade Federal do Rio de Janeiro), Clarissa M. Comim(Universidade do Extremo Sul Catarinense), Fernando A. Bozza(D’Or Institute for Research and Education), Felipe Dal‐Pizzol(Universidade do Sul de Santa Catarina), João Quevedo(The University of Texas Health Science Center), Bruno Silva(Universidade do Extremo Sul Catarinense), Tatiana Barichello, Aline Cristina Portella(Universidade Federal do Rio de Janeiro)
Cited by 127
Related Papers
A minimal common outcome measure set for COVID-19 clinical research
|The Lancet Infectious Diseases|2020|1.8k
Platelet activation and platelet-monocyte aggregate formation trigger tissue factor expression in patients with severe COVID-19
|Blood|2020|776
Cannabidiol Reduces the Anxiety Induced by Simulated Public Speaking in Treatment-Naïve Social Phobia Patients
|Neuropsychopharmacology|2011|763
Cytokine profiles as markers of disease severity in sepsis: a multiplex analysis
|Critical Care|2007|744
Lipid droplets: platforms with multiple functions in cancer hallmarks
|Cell Death and Disease|2020|530